The roles of bile acids and applications of microencapsulation technology in treating Type 1 diabetes mellitus
Type 1 diabetes mellitus (T1DM) is an autoimmune disease characterized by the loss of glycemic control. Recent studies have shown significant inflammation and disturbed bile acid homeostasis, associated with T1DM. Bile acids are endogenously produced as a result of cholesterol catabolism in the liver and solely metabolized by gut microflora. This review investigates their potential oral delivery in T1DM using targeted delivery and encapsulation technologies. A sensitive and selective search was carried out using different search engines and databases. Keywords used included diabetes mellitus, bile acids and inflammation. To conclude, bile acids have a significant impact on diabetes symptoms and, when microencapsulated, may be used as an adjunct therapy to supplement T1DM treatment.
Top-30
Journals
|
1
2
3
4
5
|
|
|
Therapeutic Delivery
5 publications, 31.25%
|
|
|
Pharmaceutics
2 publications, 12.5%
|
|
|
Biomolecules
1 publication, 6.25%
|
|
|
Frontiers in Pharmacology
1 publication, 6.25%
|
|
|
European Journal of Drug Metabolism and Pharmacokinetics
1 publication, 6.25%
|
|
|
Cell and Bioscience
1 publication, 6.25%
|
|
|
International Review of Neurobiology
1 publication, 6.25%
|
|
|
International Journal of Immunopathology and Pharmacology
1 publication, 6.25%
|
|
|
Frontiers in Bioscience - Landmark
1 publication, 6.25%
|
|
|
Chinese Medicine
1 publication, 6.25%
|
|
|
1
2
3
4
5
|
Publishers
|
1
2
3
4
5
|
|
|
Taylor & Francis
5 publications, 31.25%
|
|
|
MDPI
3 publications, 18.75%
|
|
|
Springer Nature
3 publications, 18.75%
|
|
|
Elsevier
2 publications, 12.5%
|
|
|
Frontiers Media S.A.
1 publication, 6.25%
|
|
|
SAGE
1 publication, 6.25%
|
|
|
IMR Press
1 publication, 6.25%
|
|
|
1
2
3
4
5
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.